| Dr Sagar Tushar Mehta, MD | |
|
234 Goodman St, Cincinnati, OH 45219-2364 | |
| (513) 475-8881 | |
| (513) 475-8880 |
| Full Name | Dr Sagar Tushar Mehta |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 13 Years |
| Location | 234 Goodman St, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225327224 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year's fourth quarter GAAP net income was $231 million, or $0.64 per share.
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
Mention the phrase "diverse ecosystem," and it conjures images of tropical rainforests and endangered coral reefs.
› Verified 2 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year's fourth quarter GAAP net income was $231 million, or $0.64 per share.
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
Mention the phrase "diverse ecosystem," and it conjures images of tropical rainforests and endangered coral reefs.
› Verified 2 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year's fourth quarter GAAP net income was $231 million, or $0.64 per share.
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
Mention the phrase "diverse ecosystem," and it conjures images of tropical rainforests and endangered coral reefs.
› Verified 2 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year's fourth quarter GAAP net income was $231 million, or $0.64 per share.
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
Mention the phrase "diverse ecosystem," and it conjures images of tropical rainforests and endangered coral reefs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sagar Tushar Mehta, MD Po Box 636256, Cincinnati, OH 45263-6256 Ph: (513) 585-5506 | Dr Sagar Tushar Mehta, MD 234 Goodman St, Cincinnati, OH 45219-2364 Ph: (513) 475-8881 |
News Archive
Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the year ended December 31, 2009 and provided an update on its progress.
Agilent Technologies Inc. today reported revenues of $1.17 billion for the fourth fiscal quarter ended Oct. 31, 2009, 21 percent below one year ago. Fourth quarter GAAP net income was $25 million, or $0.07 per diluted share. Last year's fourth quarter GAAP net income was $231 million, or $0.64 per share.
Adi Mehta, MD stresses the growing severity of the metabolic syndrome in the May 2010 edition of Postgraduate Medicine. Metabolic syndrome often leads to cardiovascular disease (CVD) because of its key components: diabetes, dyslipidemia, and hypertension. With obesity maintaining its status as a huge problem worldwide, physicians must act as soon as possible when they recognize metabolic syndrome or any of its components.
Brain specialists associated with the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital say the ability to incorporate in real time two high-tech imaging tools into the operating room can improve the functional abilities of patients who undergo brain surgery.
Mention the phrase "diverse ecosystem," and it conjures images of tropical rainforests and endangered coral reefs.
› Verified 2 days ago
Dr. Michael J Columbus, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 4850 Red Bank Rd, 1 Plastic Surgery Plaza, Cincinnati, OH 45227 Phone: 513-791-4440 Fax: 513-985-6615 | |
Brian S Pan, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3333 Burnet Avenue, Ml 2020, Cincinnati, OH 45229 Phone: 513-636-7181 Fax: 513-636-7182 | |
Dr. Christopher Vanbelle, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 200 Albert Sabin Way, Ml: 0461, Cincinnati, OH 45219 Phone: 513-558-4363 | |
Dr. Jennifer Lynn Butterfield, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4750 E Galbraith Rd, Suite #215, Cincinnati, OH 45236 Phone: 513-891-5610 Fax: 513-891-5638 | |
Dr. Kevin Paul Yakuboff, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3229 Burnet Ave, Shriners Hospital For Children, Cincinnati, OH 45229 Phone: 513-872-6211 Fax: 513-872-6396 | |
Megan Rudolph, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 7575 5 Mile Rd, Cincinnati, OH 45230 Phone: 513-347-9999 Fax: 513-232-2522 | |
Dr. Jon E Mendelsohn, MD FACS Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3805 Edwards Rd, Suite 100, Cincinnati, OH 45209 Phone: 513-351-3223 Fax: 513-396-8995 |